Inspire Settles AzaSite False Marking Suit
Law360 (February 15, 2011, 3:47 PM EST) -- Inspire Pharmaceuticals Inc. has agreed to pay Pharmaceutical Technologies LLC and the U.S. government a total of $150,000 to resolve a suit alleging it advertised eye infection treatment AzaSite with patents...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
